Clinical trial
Glutide for Ending Methamphetamine
NCT07204249 is registered in ClinicalTrials.gov with San Francisco Department of Public Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Glutide for Ending Methamphetamine
- Lead sponsor
- San Francisco Department of Public Health
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- February 26, 2026
- Completion date
- February 15, 2030
- Enrollment
- 162 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
methamphetamine-dependence